Scientific Programme



Click here to download the Scientific Programme in PDF format


Thursday, March 17th
REG Working Group Meetings
   Llobregat Room  Segre Room
12:00 – 13:00 Networking Lunch
 13:00 – 14:00 ILD/IPF Adherence
 14:00 – 15:00 Allergy Database & Coding
 15:00 – 16:00 Cost Effectiveness COPD
 16:00 – 16:30
Coffee Break
 16:30 – 17:30 Environment, Epidemiology and Airways Biomarkers & Severe Asthma
 17:30 – 18:30 Technologies
Child Health
Friday, March 18th
Plenary Sessions
   Plenary Room
08:50 – 09:00 Welcome
Prof. Sinthia Bosnic-Anticevich
09:00 – 09:45 COVID-19 infection

Targeting the end of the COVID-19 pandemic
Speaker: Prof. Joan B. Soriano
09:45 – 10:30 REG-APAAACI Joint Symposium - Rhinitis and Asthma
Chair: Prof. Ruby Pawankar & Dr. Iñigo Ojanguren

COVID-19 Allergies and asthma: Asia Pacific Perspectives
Prof. Ruby Pawankar

Asthma and Chronic Rhinosinusitis with Nasal Polypsosis
Prof. G. Walter Canonica

Real world data for rhinitis and asthma
Prof. Jean Bousquet
10:30 – 11:00 Coffee Break
11:00 – 12:00 Asthma in Children - Diagnosis, Monitoring, Treatment
Chair: Dr. James Paton & Prof. Clare Murray

The new ERS Pediatric Asthma Diagnosis Recommendation
Prof. Alexander Moeller

The New PeARL Asthma Monitoring Recommendations
Prof. Nikos Papadopoulos

The New GINA Treatment Suggestions for Children
Dr. Paulo Pitrez
12:00 – 12:30 Poster Viewing
12:30 – 13:30 Lunch Break
13:30 – 15:00
COPD Session
Chair: Prof. Nicolas Roche & Prof. Janwillem Kocks

13:30 – 13:50
Antibiotics for Prevention of Chronic Lung Disease Exacerbations
Prof. Therese Lapperre
13:50-14:40 Roundtable: Pharmacotherapy in COPD and Mortality
Speaker: Prof. David Halpin
Panel: Prof. Mona Bafadhel, Dr. Marc Miravitlles
14:40-15:00 COPD Control, Does this Work in Practice?
Dr. Marc Miravitlles
15:00 – 15:30 Coffee Break
15:30 – 17:45 Crossroads in Respiratory Care

Chair: Dr. Dermot Ryan & Dr. Omar Usmani
15:30 – 16:15 A. GINA 2021 – A two track approach to asthma management (PRO/CON)
PRO: Prof. Helen Reddel
CON: Dr. Désirée Larenas-Linnemann
Chair: Prof. Andre Menzies-Gow & Prof. Celeste Porsbjerg
16:15 – 17:00 B. Do we need a sixth asthma biologic? (PRO/CON)
PRO: Dr. Kostas Kostikas
CON: Prof. Christian Virchow
Chair: Dr. Omar Usmani & Dr. Dermot Ryan
17:00 – 17:45 C. Triple Therapy in asthma? (PRO/CON)
PRO: Prof. Alberto Papi
CON: Dr. Renaud Louis
Saturday, March 19th
Plenary Sessions
   Plenary Room
09:00 – 09:30 ILD session
Chair: Dr. Maria Molina-Molina

Post-COVID fibrosis and other ILDs – new perspectives
Dr. Pilar Rivera Ortega

09:30 – 11:00 The International Severe Asthma Registry (ISAR): Key Updates and Research Findings
Chair: Prof. Andrew Menzies-Gow

ISAR through time: Achievements and our vision for the future
Prof. David Price

Prevalence of comorbidities and their impact on clinical outcomes in severe asthma patients (PRISM project)
Dr. Celeste Porsbjerg

Characterisation of patients with non-Type 2 asthma and assessment of biologic effectiveness in patients with different Type 2 biomarkers (EMBER and IGNITE projects)
Dr. Todor Popov

Defining and characterising biologic treatment responders in severe asthma patients (BEAM project)
Prof. Andrew Menzies-Gow

Impact of biologic initiation on clinical outcomes in severe asthma patients with high exposure to oral corticosteroids (GLITTER project)
Dr. Carlos Torres

Comparing the effectiveness of Anti-IL5 versus Anti-IgE biologic therapies in severe asthma patients eligible for both (FIRE project)
Prof. David Price
11:00 – 11:30 Coffee Break
11:30 – 12:15 Digital technology advances in respiratory medicine the potential to improve patient outcomes
Chair: Dr. Ron Dandurand & Dr. Esther Metting
Speaker: Prof. Job van Boven
12:15 – 13:00 The Future of Real-Life Research
Chair: Prof. Sinthia Bosnic-Anticevich & Prof. G. Walter Canonica

The role of patient insights in getting research funding and improving research
Dr. Samantha Walker

HCP Perspective
Prof. David Price
13:00 Meeting Close